申请人:Merck & Co., Inc.
公开号:US06376496B1
公开(公告)日:2002-04-23
The present invention comprises piperazine-containing compounds which inhibit prenyl-protein transferases, including farnesyl-protein transferase and geranylgeranyl-protein transferase type I. Such therapeutic compounds are useful in the treatment of cancer.
这项发明涉及含有哌嗪的化合物,可以抑制前萜基蛋白转移酶,包括法尼基蛋白转移酶和戊二烯基蛋白转移酶I型。这种治疗性化合物在癌症治疗中很有用。